Minimally Invasive

Subchondroplasty

Next-generation subchondral bone repair and therapy.

Product Overview

The Subchondroplasty® (SCP®) Procedure is a minimally invasive surgery enabling surgeons to target and treat subchondral bone defects, often referred to as Bone Marrow Lesions (BMLs).

Subchondroplasty® (SCP®)

A minimally-invasive, fluoroscopically-assisted intervention that targets and fills subchondral bone defects, often called Bone Marrow Lesions (BML), with AccuFill® Bone Substitute Material. Usually performed along with arthroscopy to aid in visualization.

Key Highlights

Nanocrystalline, highly porous injectable calcium phosphate (CaP)
Mimics chemical composition/structure of natural human bone
Flows to fill defects, hardens isothermally at 37°C
Replaced with new bone during the healing process
AccuPort Cannulas: 11G (side/end) and 15G (end)

Technical Data

MaterialAccuFill® BSM (Injectable CaP)

ReactionIsothermic Crystallization at 37°C

Cannulas11G (Side/End) & 15G (End)

ComponentsCannula + Stylus

ApplicationKnee, Foot & Ankle, Shoulder, Hip

System Features

Minimally-invasive BML treatment
Fluoroscopically-assisted targeting
AccuFill® BSM: Injectable Calcium Phosphate
Isothermic setting at body temperature (37°C)
Biocompatible and resorbable

Clinical Benefits

Does not inhibit other intra-articular treatments
Restores structural integrity to subchondral bone
Mimics natural bone structure for integration
Minimally invasive with rapid recovery potential

Contact Us

Let's Collaborate on Your Healthcare Needs.

Visit Our Office

E-1-2, Parklane Commercial Hub,

Jalan SS 7/26, SS7,

47301 Petaling Jaya, Selangor, Malaysia